Download
incident patient counts figure p 1 by modality data source n.
Skip this Video
Loading SlideShow in 5 Seconds..
Incident patient counts figure p.1, by modality & data source PowerPoint Presentation
Download Presentation
Incident patient counts figure p.1, by modality & data source

Incident patient counts figure p.1, by modality & data source

0 Views Download Presentation
Download Presentation

Incident patient counts figure p.1, by modality & data source

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Incident patient countsfigure p.1, by modality & data source

  2. Prevalent patient countsfigure p.2, by modality & data source

  3. Transplant countsfigure p.3, by data source

  4. Summary statistics on reported ESRD therapy in the United States, 2000table p.a

  5. Summary statistics on reported ESRD therapy in the United States, 2000table p.a (cont.)

  6. Summary statistics on reported ESRD therapy in the United States, 2000 table p.a (cont.)

  7. Summary statistics on reported ESRD therapy in the United States, 2000 table p.a (cont.)

  8. Summary statistics on reported ESRD therapy in the United States, 2000 table p.a (cont.)

  9. Annual percent changes in patient counts figure p.4, incident ESRD patients illi illi lla lla

  10. Annual percent changes in patient counts figure p.4, incident ESRD patients (cont.)

  11. Trends in counts of new dialysis patients figure p.5

  12. Patient losses: trends in patients ceasing dialysisfigure p.6

  13. Patient losses: trends in patients lost-to-followupfigure p.7, point prevalent ESRD patients

  14. Trends in Medicare vs. non-Medicare spendingfigure p.8

  15. Counts of patients 67 & older figure p.9 incident ESRD patients

  16. Percent of patients, by insurance type figure p.10, incident ESRD patients

  17. Hemoglobin & EPO use in the pre-ESRD periodfigure p.11, incident patients, 1995-1999 combined

  18. Pre-ESRD EPO use in patients 67 & older: Trends in pre-ESRD EPO, by data sourcefigure p.12, FFS patients with ME forms

  19. Patients receiving EPO in the two years pre-ESRD: patients age 67 & olderfigure p.13, FFS patients Percent of patients

  20. Patients receiving EPO in the two years pre-ESRD: patients age 67 & olderfigure p.13, FFS patients

  21. Primary causes of hospitalization in the pre-ESRD period: patients 67 & olderfigure p.14, FFS patients, 1995-1999 combined

  22. Access placement prior to ESRDfigure p.15, patients 67 & older

  23. Access placement at start of ESRD: Cathetersfigure p.16, incident patients age 67 & older, 1995-1999 combined, by HSA Percent of patients 45.5+ (49.1) 42.3 to <45.5 39.8 to <42.3 37.5 to <39.8 below 37.5 (34.7)

  24. Access placement at start of ESRD: Fistulasfigure p.16, incident patients age 67 & older, 1995-1999 combined, by HSA (cont.) Percent of patients 11.03+ (13.86) 8.87 to <11.03 7.21 to <8.87 5.72 to <7.21 below 5.72 (4.67)

  25. Access placement at start of ESRD: Graftsfigure p.16, incident patients age 67 & older, 1995-1999 combined, by HSA (cont.) Percent of patients 17.0+ (21.2) 14.1 to <17.0 12.1 to <14.1 10.0 to <12.1 below 10.0 (8.3)

  26. Pre-ESRD diabetic preventive carefigure p.17, diabetic incident patients, 1999

  27. ESRD patients, by diagnosis & origins in the general Medicare population figure p.18, 1997-1998 general Medicare patients

  28. ESRD patients, by diagnosis & origins in the general Medicare population figure p.18, 1997-1998 general Medicare patients (cont.)

  29. ESRD patients, by diagnosis & origins in the general Medicare population figure p.18, 1997-1998 general Medicare patients (cont.)

  30. CKD in the general Medicare population, by age figure p.19

  31. Prevalence of diabetes & chronic kidney disease in the general Medicare populationfigure p.20

  32. Geographic variations in prevalence of diabetes & chronic kidney diseasefigure p.21, general Medicare patients age 65 & older, 1998-1999 combined Percent of patients 18.5+ (19.8) 17.6 to <18.5 16.5 to 17.6 15.0 to <16.5 below 15.0 (14.1)

  33. Geographic variations in prevalence of diabetes & chronic kidney diseasefigure p.21, general Medicare patients age 65 & older, 1998-1999 combined Percent of patients 4.05+ (4.35) 3.74 to <4.05 3.51 to <3.74 3.15 to <3.51 below 3.15 (2.94)

  34. Development of ESRD & mortality in the general Medicare population figure p.22, 1996-1997 combined

  35. Life table estimates for the probability of developing ESRDfigure p.23, general Medicare patients, 1996-1997 combined Followup time (months)

  36. Life table estimates for the probability of deathfigure p.23, general Medicare patients, 1996-1997 combined (cont.)

  37. Identified diseases, by data sourcefigure p.24, patients age 65 & older

  38. Glomerular filtration rate & hemoglobin levels (NHANES III data)figure p.25, patients age 65 & older

  39. Hospital admissions, by vintage & modalityfigure p.26, period prevalent ESRD patients, 2000

  40. Trends in admissions, by vintage & modalityfigure p.27, period prevalent ESRD patients

  41. Geographic variations in hospital admission rates: dialysisfigure p.28, period prevalent ESRD patients, 2000, by HSA, unadjusted Admissions per 1,000 patient years at risk 2,270+ (2,530) 1,990 to <2,270 1,790 to <1,990 1,580 to <1,790 below 1580 (1,410)

  42. Geographic variations in hospital admission rates: transplantfigure p.28, period prevalent ESRD patients, 2000, by HSA, unadjusted Admissions per 1,000 patient years at risk 908+ (1,105) 775 to <908 679 to <775 594 to <679 below 594 (517)

  43. Geographic variations in hospital days: dialysisfigure p.29, period prevalent ESRD patients, 2000, by HSA, unadjusted Hospital days per patient year at risk 16.10+ (19.68) 13.53 to <16.10 11.35 to <13.53 9.25 to <11.35 below 9.25 (6.95)

  44. Geographic variations in hospital days: transplantfigure p.29, period prevalent ESRD patients, 2000, by HSA, unadjusted Hospital days per patient year at risk 6.81+ (11.91) 4.52 to <6.81 2.96 to <4.52 1.44 to <2.96 below 1.44 (0.88)

  45. Mortality rates, by vintage & modality figure p.30, period prevalent ESRD pts, 1998-2000 combined, unadjusted

  46. Mortality rate trends, by vintage & modalityfigure p.31, period prevalent ESRD patients, unadjusted

  47. First- & second-year mortality rates, by modality figure p.32, incident ESRD patients, adjusted for age, gender, race, & primary diagnosis

  48. Geographic variations in mortality rates: Dialysisfigure p.33, period prevalent ESRD pts, 2000, by HSA, unadjusted Deaths per 1,000 patient years at risk 268+ (282) 253 to <268 242 to <253 223 to <242 below 223 (208)

  49. Geographic variations in mortality rates: Transplantfigure p.33, period prevalent ESRD pts, 2000, by HSA, unadjusted Deaths per 1,000 patient years at risk 37.1+ (39.1) 35.6 to <37.1 34.2 to <35.6 33.1 to <34.2 below 33.1 (31.2)

  50. Trends in patient & unit counts: for-profit & non-profit unitsfigure p.34, dialysis patients